CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates Amid Clinical Progress TLF Q1 2026 Earnings Modest Profitability Amid Quiet Quarter APRE Q1 2026 Earnings Narrower Loss Beats Estimates Stock Rises 215 Vaxcyte PCVX Q1 2026 Earnings PreRevenue Biotech Posts WiderThanExpected Loss Stock Gains on Pipeline Confidence MPWR Q1 2026 Earnings EPS Exceeds Expectations Amid Strong Demand XELLL Q1 2026 Earnings Marginal EPS Miss Amid Stable Utility Operations